NAMSA
Medical device focused CRO covering biocompatibility, preclinical surgical and interventional research, histopathology and regulatory consulting. Its Minneapolis preclinical site (formerly American Preclinical Services)…
10 contract research organizations in our directory list In Vivo Imaging as a capability, across 7 countries. 6 report GLP capability and 0 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.
In vivo imaging lets a study follow the same animal over time, so tumor growth, drug distribution or disease progression can be measured repeatedly instead of by sacrificing groups at each time point. It reduces animal numbers and often reduces variability, because each animal serves as its own baseline.
Each modality answers a different question. Bioluminescence (BLI) and fluorescence imaging are inexpensive and fast, and are widely used to track luciferase-tagged tumor cells in orthotopic and metastatic oncology models or to follow labeled cells after administration. PET and SPECT measure the distribution of a radiolabeled drug, antibody or tracer quantitatively and translate directly to the clinic, which makes them useful for biodistribution, target engagement and receptor occupancy. MRI and CT give anatomical detail for CNS, cardiac, orthopedic and implant work, and ultrasound is common for cardiac function and guided injections.
For cell therapy and regenerative medicine programs, in vivo cell tracking combines a reporter gene or label with imaging to show where administered cells go and how long they persist. Confirm the CRO has the scanner, the radiochemistry or labeling support, and the analysis pipeline your endpoint needs, since these are often split between groups.
Showing 10 CROs. Order rotates daily so no lab is permanently listed first.
Medical device focused CRO covering biocompatibility, preclinical surgical and interventional research, histopathology and regulatory consulting. Its Minneapolis preclinical site (formerly American Preclinical Services)…
Shanghai CRO centered on nonhuman primate efficacy and safety studies, with NHP disease models across metabolism, cardiovascular, renal, neurology and ophthalmology, clinical-style imaging and interventional surgery.
Wuhan CRO integrating NHP breeding with toxicity and safety evaluation, PK/PD, molecular imaging and bioanalysis.
Translational testing and training laboratory in metro Atlanta supporting large animal preclinical device research, surgical models and procedural training.
Spanish translational research center offering GLP and non-GLP large animal studies, device validation, advanced imaging and surgical training.
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
Minnesota company providing preclinical services and reagents for oncolytic virus, gene and cell therapy programs, including reporter imaging and efficacy models.
Danish preclinical imaging CRO offering PET, SPECT, CT and MRI studies, radiopharmaceutical development support and oncology efficacy models.
Montreal-based neuroscience CRO combining neurodegenerative disease models with MRI imaging, quantitative neuropathology and image analysis.
Israeli large animal CRO offering GLP and non-GLP surgical, interventional and imaging-supported studies for devices and therapeutics.